BANK OF MONTREAL /CAN/ - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 102 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2021$33,000
-76.3%
1,185
-73.1%
0.00%
Q4 2020$139,000
-93.4%
4,413
-92.8%
0.00%
-100.0%
Q3 2020$2,120,000
-50.2%
60,999
-25.8%
0.00%
-50.0%
Q2 2020$4,253,000
+22284.2%
82,241
+14202.8%
0.00%
Q1 2020$19,000
-91.5%
575
-84.7%
0.00%
Q4 2019$224,000
+121.8%
3,762
+36.2%
0.00%
Q3 2019$101,000
-19.2%
2,762
+3.4%
0.00%
Q2 2019$125,000
+443.5%
2,671
+364.5%
0.00%
Q1 2019$23,000
-43.9%
575
-36.0%
0.00%
Q4 2018$41,000
+24.2%
898
+22.5%
0.00%
Q3 2018$33,000
+13.8%
733
-0.7%
0.00%
Q2 2018$29,000
-31.0%
738
+28.3%
0.00%
Q1 2018$42,000
-91.6%
575
-92.4%
0.00%
Q4 2017$500,000
+525.0%
7,596
+375.9%
0.00%
Q3 2017$80,000
+185.7%
1,596
+167.8%
0.00%
Q2 2017$28,000
-88.0%
596
-91.0%
0.00%
Q1 2017$233,000
+3783.3%
6,596
+1006.7%
0.00%
Q4 2016$6,000
-40.0%
596
-14.1%
0.00%
Q3 2016$10,000
-95.3%
694
-96.8%
0.00%
Q2 2016$215,000
+43.3%
21,735
+144.2%
0.00%
Q1 2016$150,000
+4.2%
8,901
+36.7%
0.00%
Q4 2015$144,000
+1500.0%
6,512
+1600.3%
0.00%
Q3 2015$9,000
-55.0%
383
+53.2%
0.00%
Q2 2015$20,000
-91.7%
250
-90.4%
0.00%
Q1 2015$241,000
+588.6%
2,604
+204.9%
0.00%
Q4 2014$35,000
+66.7%
8540.0%0.00%
Q3 2014$21,000
+950.0%
854
+676.4%
0.00%
Q2 2014$2,0001100.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2016
NameSharesValueWeighting ↓
Meditor Group Ltd 2,818,835$59,618,00021.09%
Bellevue Group AG 4,519,164$95,580,0000.93%
PLATINUM INVESTMENT MANAGEMENT LTD 1,713,176$36,234,0000.84%
Rhenman & Partners Asset Management AB 572,267$12,103,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 64,434$1,363,0000.45%
Boxer Capital, LLC 500,000$10,575,0000.37%
EMC Capital Management 27,566$583,0000.33%
WASATCH ADVISORS LP 3,766,935$79,671,0000.32%
Avidity Partners Management LP 400,000$8,460,0000.23%
Cinctive Capital Management LP 186,170$3,937,0000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders